<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A representative number of prospective studies clearly indicate that <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality is significantly increased in type-2 diabetic patients in comparison with non-diabetic control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>The cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo> rate is 4.4 fold increased in those diabetic patients presenting none of the classical risk factors (<z:hpo ids='HP_0000822'>hypertension</z:hpo>, hypercholesterinemia or smoking) compared with age-matched control subjects (MRFIT) </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:mp ids='MP_0008770'>decreased survival rate</z:mp> after <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> and an increased occurrence of silent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> are responsible for the poor prognosis of type-2 diabetic patients </plain></SENT>
<SENT sid="3" pm="."><plain>Recent studies indicate that haemostatic abnormalities and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> are important risk factors for coronary events in diabetic as well as in nondiabetic patients </plain></SENT>
<SENT sid="4" pm="."><plain>In newly diagnosed type-2 diabetic patients a similar prevalence of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:mp ids='MP_0006112'>angina</z:mp> compared to previously known type-2 <z:mp ids='MP_0002055'>diabetes</z:mp> was found </plain></SENT>
<SENT sid="5" pm="."><plain>The long <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> period and clustering of risk factors may be very relevant for the high prevalence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> already at diagnosis of type-2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>More recent studies performed in Scotland and Verona demonstrated a mortality risk approximately only 50% higher than in nondiabetic subjects </plain></SENT>
<SENT sid="7" pm="."><plain>The reduction in the mortality risk could reflect an improvement in <z:mp ids='MP_0002055'>diabetes</z:mp> prognosis from the 1960s to the 1980s </plain></SENT>
<SENT sid="8" pm="."><plain>Recent observations in type-2 diabetic patients from Finland indicate that glycemic control is an important predictor for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> morbidity and mortality </plain></SENT>
<SENT sid="9" pm="."><plain>However incidence of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> is only low in those patients presenting with a HbAlc value below 6.0% </plain></SENT>
<SENT sid="10" pm="."><plain>More information will be available after analysis of the United Kingdom prospective <z:mp ids='MP_0002055'>diabetes</z:mp> study </plain></SENT>
<SENT sid="11" pm="."><plain>(UKPDS) </plain></SENT>
</text></document>